DALLAS, February 5 /PRNewswire/ --

- Large Equity Investment from Kuwait Announced Today

Just as oil is reaching the US$100 per barrel mark, Dallas-based Synfuels International, Inc. announced a transaction, which will make it practical to produce millions of barrels of new petroleum products and help reduce sources of global warming.

SANTA CLARA, California, February 5 /PRNewswire/ --

- Samsung Selects Marvell Processor for Accelerated Processing and Superior Multimedia Capabilities

WELLESLEY HILLS, Massachusetts, February 5 /PRNewswire/ --

Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced today that The Committee for Orphan Drug Products of the European Medicines Agency (EMEA) has granted Orphan Drug Designation for M40403 for the prevention of oral mucositis (OM) in head and neck cancer patients receiving radiotherapy.

The development of oral mucositis during radiation therapy of head and neck cancers is the major reason for poor compliance with and early discontinuation of radiation therapy by patients being treated for their condition.

CHELMSFORD, Massachusetts, February 5 /PRNewswire/ --

- Companies team to simplify 3G home networking deployments

Airvana, Inc. (Nasdaq: AIRV), the company transforming the mobile experience, and Thomson (Euronext 18453; NYSE: TMS), a world leader in media and communications technologies, today announced that they entered into a global sourcing agreement for Airvana's Universal Mobile Telecommunication System (UMTS) femtocell technology. As a result of the agreement, Thomson will use Airvana's femtocell products in conjunction with their own residential gateways.

DUSSELDORF, Germany, February 5 /PRNewswire/ --

Arnaud de Meulemeester, who for the last three years has led the telematics program for PSA Peugeot Citroen, has been named Senior Director in Europe for ATX Group, the world's largest independent telematics provider to the automotive industry.

LONDON, February 5 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the online 'front door' to the NHS, today launched a new diabetes symptom checker.

Based on NHS accredited information, the diabetes symptom checker (http://www.nhs.uk/Tools/Pages/diabetes.aspx) enables users to find out in minutes whether they are at risk of having diabetes. It also provides them with clinically approved guidance on what their results mean and what next steps, if any, may be required. This interactive tool is the latest addition to the NHS Choices' extensive tool library.